Project 4

$222,780P20FY2015GMNIH

University Of Oklahoma Hlth Sciences Ctr, Oklahoma City OK

Investigators

Linked publications & trials

Paper 32792587 Paper 30716067 Paper 30649208 Paper 30307502 Paper 30029250 Paper 29905772 Paper 29721978 Paper 29684583 Paper 29217410 Paper 29183319 Paper 28979999 Paper 28848738 Paper 28813718 Paper 28734946 Paper 28657902 Paper 28601428 Paper 28545982 Paper 28455497 Paper 28400700 Paper 28270521 Paper 28154187 Paper 28041994 Paper 27914705 Paper 27870419 Paper 27672025 Paper 27620389 Paper 27543085 Paper 27528615 Paper 27480221 Paper 27473938 Paper 27242197 Paper 26866626 Paper 26865060 Paper 26799652 Paper 26781278 Paper 26702098 Paper 26476002 Paper 26471128 Paper 26468277 Paper 26340932 Paper 26324504 Paper 26069721 Paper 26068541 Paper 26061789 Paper 26055327 Paper 25961473 Paper 25889867 Paper 25871009 Paper 25796186 Paper 25720766 Paper 25719498 Paper 25663658 Paper 25657312 Paper 25541949 Paper 25476852 Paper 25403501 Paper 25377875 Paper 25271989 Paper 25271056 Paper 25266791 Paper 25185133 Paper 25112876 Paper 25108226 Paper 24853093 Paper 24845641 Paper 24825105 Paper 24788415 Paper 24744608 Paper 24664724 Paper 24664691 Paper 24616481 Paper 24560422 Paper 24463424 Paper 24406409 Paper 24374736 Paper 24274545 Paper 24130179 Paper 24003152 Paper 23884893 Paper 23842729 Paper 23795287 Paper 23611999 Paper 23406904 Paper 23404117 Paper 23211829 Paper 23211825 Paper 23056421 Paper 22935961 Paper 22915031 Paper 22772755 Paper 22512451 Paper 22215709 Paper 22130180 Paper 21782811 Paper 21676174 Paper 21360191 Paper 21253511 Paper 21235714 Paper 20946832 Paper 20530741

Abstract

Diabetes is one of a broad range of human diseases and disorders that are directly associated with endoplasmic reticulum (ER) malfunction. This malfunction is termed ER stress (ERS) and results from the accumulation of luminal unfolded/misfolded proteins. Cellular response to ERS is regulated by the Unfolded Protein Response (UPR) and will result in either ERS attenuation or apoptosis. ERS leading to cell death is often observed in type 2 diabetes when pancreatic p-cells are placed under high insulin production loads to maintain euglycemia. This proposal is focused on understanding the function and activity of the soluble 78 kDa Glucose-Regulated protein (GRP78) that serves as a molecular chaperone to facilitate protein folding in the ER lumen. GRP78 is a master regulator of UPR activity and thus plays a significant role in determining cellular response to ERS. To accomplish this objective we will utilize a novel family of small molecules called FlexHets that are now known to target GRP78 function. The focus in AIM 1 is to determine if FlexHet inhibition of GRP78 activity enhances insulin receptor signaling and response. AIM 2 is focused on determining the molecular basis for FlexHet binding to GRP78 as a means to understand GRP78 function and regulation by small molecule therapeutics. AIM 3 uses in vivo mouse models to determine if GRP78 inhibition modulates ERS response and signaling in obese vs. non-obese diabetic mice. Thus, our approach is to combine a range of in vitro and in vivo methods to develop a holistic model of GRP78 function by utilizing FlexHets as a targeted molecular tool to inhibit GRP78 function and activity. GRP78 has been previously shown to play a key role in insulin signaling using heterozygous knockout mice so the current studies are aimed at understanding the molecular basis for this observation and vetting GRP78 as a viable candidate for therapeutic intervention in the treatment of type 2 diabetes.

View original record on NIH RePORTER →